PLSH logo

Panacea Life Sciences Holdings OTCPK:PLSH Stock Report

Last Price

US$0.10

Market Cap

US$2.1m

7D

66.4%

1Y

-44.4%

Updated

23 Nov, 2024

Data

Company Financials

Panacea Life Sciences Holdings, Inc.

OTCPK:PLSH Stock Report

Market Cap: US$2.1m

PLSH Stock Overview

Operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. More details

PLSH fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Panacea Life Sciences Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Panacea Life Sciences Holdings
Historical stock prices
Current Share PriceUS$0.10
52 Week HighUS$0.35
52 Week LowUS$0.038
Beta3.2
11 Month Change10.80%
3 Month Change5.99%
1 Year Change-44.44%
33 Year Change-90.00%
5 Year Changen/a
Change since IPO-97.37%

Recent News & Updates

Recent updates

Shareholder Returns

PLSHUS PharmaceuticalsUS Market
7D66.4%1.6%2.2%
1Y-44.4%10.0%31.7%

Return vs Industry: PLSH underperformed the US Pharmaceuticals industry which returned 10.8% over the past year.

Return vs Market: PLSH underperformed the US Market which returned 31.1% over the past year.

Price Volatility

Is PLSH's price volatile compared to industry and market?
PLSH volatility
PLSH Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement9.7%
Market Average Movement6.3%
10% most volatile stocks in US Market15.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: PLSH's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine PLSH's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200840Leslie Buttorffwww.panacealife.com

Panacea Life Sciences Holdings, Inc., operates as a holding company, develops, manufactures, research, produces, and distributes hemp-derived cannabinoid, functional mushroom, Kratom, plant-based ingredients, and nutraceutical products for consumers and pets. The company also involved in the white label and contract manufacturing sales to other hemp companies, raw material sales, and tolling arrangements. In addition, it offers natural remedies under the PANA Health, PANA Beauty, PANA Pet, PANA Sport, PANA Pure, and PANA Life brand name.

Panacea Life Sciences Holdings, Inc. Fundamentals Summary

How do Panacea Life Sciences Holdings's earnings and revenue compare to its market cap?
PLSH fundamental statistics
Market capUS$2.08m
Earnings (TTM)-US$7.67m
Revenue (TTM)US$2.76m

0.8x

P/S Ratio

-0.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
PLSH income statement (TTM)
RevenueUS$2.76m
Cost of RevenueUS$6.63m
Gross Profit-US$3.87m
Other ExpensesUS$3.80m
Earnings-US$7.67m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.37
Gross Margin-139.86%
Net Profit Margin-277.51%
Debt/Equity Ratio-163.5%

How did PLSH perform over the long term?

See historical performance and comparison